Type 2 Diabetes Restricts Multipotency of Mesenchymal Stem Cells and Impairs Their Capacity to Augment Postischemic Neovascularization in Db/Db Mice
Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.112.002238
Full Text
Open PDFAbstract
Available in full text
Date
November 29, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)